Investigative Site #110 — St Louis, Missouri

Investigative Site #110 is a clinical research site located in St Louis, Missouri, United States 63108.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Investigative Site #110 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Advanced Solid Tumor, Metastatic Solid Tumor, Endometrial Cancer.

Sponsors: MOMA Therapeutics.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site #110?

Investigative Site #110 has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site #110 conducted?

Investigative Site #110 has 2 clinical trials on record, with 2 currently active. Their work covers Advanced Solid Tumor, Metastatic Solid Tumor, Endometrial Cancer.

Is Investigative Site #110 accredited by Crixeo Health?

Investigative Site #110 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigative Site #110?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.